Chemours President and CEO Mark Vergnano recently stated in Shanghai that the company is considering increasing its titanium dioxide production capacity and is currently seeking suitable opportunities and locations.
On July 1, 2015, Chemours was acquired from the world's second-largest chemical company, Du Chemical, in the United States Bangzhan Separated and independently listed on the New York Stock Exchange, headquartered in Wilmington, Delaware, USA. It inherits DuPont's over 200 years of experience in chemical research and production, enjoys a long tradition of innovation and multiple industry-leading technologies, and is a reliable, safe, and high-quality leader in the chemical production industry. At present, it has 58 factories and laboratories worldwide, with over 7000 employees, serving customers in more than 130 countries and regions worldwide.
Chemours is a market leader in the three major business areas of titanium dioxide products, fluorine products, and specialty chemicals. Among them, titanium dioxide ranks first in the market, and fluoropolymer has the highest market share and global supply capacity.
Marko stated that China is a very important market for Chemours, accounting for 10% of Chemours's global revenue. Moreover, Chemours can see potential huge growth opportunities in the Chinese market. In fact, China is the world's largest titanium dioxide market and also the fastest-growing titanium dioxide market in the world. Moreover, China has gradually become one of the markets with the most users of fluoropolymers, including some fluoropolymers and fluorochemicals.
According to his introduction, Chemours currently has 4 factories and 3 offices in Chinese Mainland, and also has a technology research and development center in Shanghai.
Marko stated that China is also one of the options for Chemours to establish a titanium dioxide factory, but the company has not yet made a final decision. Chemours's last expansion of titanium dioxide production capacity occurred two years ago. The company's factory in Mexico was put into operation in 2016, increasing its annual titanium dioxide production capacity to 1.25 million tons.
According to data, in 2018, the total sales of Chemours amounted to 6.6 billion US dollars, with an EBITDA of 1.74 billion US dollars. Nearly half of the company's sales come from the titanium dioxide technology business.
Marko stated that the performance of the titanium dioxide technology business unit may not be as good as last year, but the company also expects good profitability in the two businesses of fluoropolymers and specialty chemicals, and remains optimistic about the company's development prospects.
In Marko's view, all activities undertaken by Chemours are synchronized with the current development in China.
Speaking about the upcoming second China International Import Expo in November this year, Makno said that Chemours did not participate in the first CIIE, but a comprehensive evaluation will be conducted this year to determine whether to participate in the second CIIE.
If there is a suitable opportunity and way to participate in the second CIIE, we will also maintain a very honest and open attitude
